Krish W. Ramadurai work email
- Valid
- Valid
- Valid
Krish W. Ramadurai personal email
Krish is a Partner at AIX Ventures, where he leads the firm's technical due diligence, investment sourcing, and portfolio operational support across their artificial intelligence, healthcare, and life sciences practices. He has led and managed 40+ early and growth stage investments across multiple top-decile performing funds with a cumulative portfolio enterprise value of $10B+ and an extensive track record of success with exits including Volumetric Biotechnologies (Acquired by 3D Systems), PathologyWatch (Acquired by Sonic Healthcare), Trials.AI (Acquired by ZS Associates), and Insilico Medicine (IPO Announced). He has backed over 20 major scientific breakthroughs spanning the world's first AI-designed drug in human trials and the first drug discovered through a 3D bioprinted tissue disease model to the launch of the first commercial rideshare satellite into space. Furthermore, he is a Harvard & Oxford-trained scientist and biomolecular engineer, multi-published author, advisor, lecturer, and former researcher at Harvard & MIT. While at Harvard, he worked with former United States Secretary of Defense Ash Carter and Nobel Laureate Economist Michael Kremer on the United States Agency for International Development (USAID) Development Innovation Ventures Fund and published three internationally-released books on applied engineering and medicine featured in Barnes & Noble and the Oxford, MIT, Harvard, Yale, and Princeton library collections. He has held chairman and board positions for multiple companies and is a venture advisor for Nucleate and the National Venture Capital Association (NVCA) Venture Forward Program, and a member of Oxford University's Institute of Biomedical Engineering (IBME), American Society of Biomechanics (ASB), the American Institute of Chemical Engineers (AIChE), and the Advanced Research Projects Agency for Health (ARPA-H). His thought leadership on AI-enabled life sciences, healthcare, and technology has been featured in leading media outlets, including the Wall Street Journal, Venture Capital Journal, Yahoo Finance, NBC, World Economic Forum, Economy Middle East, TechBullion, Apple Podcasts, Funds Europe Magazine, Pulse 2.0, and Nikkei Asia.
-
PartnerAix Ventures Aug 2024 - PresentSan Francisco, UsInvesting at the intersection of Healthcare, Life Sciences, and Artificial Intelligence: https://www.aixventures.com/ -
InvestorVevo Therapeutics Aug 2024 - Present -
InvestorEllipsis Health Aug 2024 - PresentSan Francisco, California, Us -
InvestorAmbience Healthcare Aug 2024 - PresentSan Francisco, Ca, Us -
InvestorProfluent Aug 2024 - PresentEmeryville, Ca, Us -
InvestorHugging Face Aug 2024 - PresentUs -
InvestorPerplexity Aug 2024 - PresentSan Francisco, California, Us -
Guest LecturerHarvard University May 2017 - PresentCambridge, Massachusetts, UsInvited lecturer in the Faculty of Arts & Sciences for undergraduate and graduate Tissue Engineering for Clinical Applications and Biochemical Engineering & Synthetic Life courses with 25+ lectures given to date -
Investor MemberAdvanced Research Projects Agency For Health (Arpa-H) Oct 2024 - PresentBethesda, Md, UsInvestor Catalyst Hub Spoke Member -
Venture MentorNational Venture Capital Association Apr 2023 - PresentWashington, Dc, Us -
Venture AdvisorNucleate Oct 2021 - PresentBoston, UsNucleate is dedicated to empowering the next generation of biotech leaders who transform experiments into enterprises -
Board Chairman & InvestorPrecipoint Jun 2023 - Aug 2024Garching, Bavaria, De -
Board Observer & InvestorXcures Aug 2022 - Aug 2024Oakland, California, Us -
Board Observer & InvestorSorcero Jan 2022 - Aug 2024Washington, District Of Columbia, Us -
InvestorBit.Bio Sep 2021 - Aug 2024Cambridge, Cambridgeshire, Gb -
InvestorAttivare Therapeutics Aug 2021 - Aug 2024 -
InvestorCaresyntax Jul 2021 - Aug 2024San Francisco, Ca, Us -
InvestorLoft Orbital Jul 2021 - Aug 2024San Francisco, Ca, Us -
InvestorBioz Apr 2021 - Aug 2024Palo Alto, California, Us -
InvestorSana Health Apr 2021 - Aug 2024Louisville, Colorado, Us -
InvestorParadromics Inc. Mar 2021 - Aug 2024Austin, Texas, Us -
InvestorAether Mar 2021 - Aug 2024Menlo Park, California, Us -
PartnerHarmonix Fund Nov 2020 - Aug 2024La Quinta, California, Us• Managed top-decile performing venture capital fund with a proven track record of 40+ investments in healthcare, life sciences, and deep technology with a cumulative portfolio enterprise valuation of $7B+ across Funds I & II with four exits, including 1 IPO and 3 acquisitions.• Sourced and led due diligence for 30 investments across early and growth stages, composed in-depth investment memorandums for investment committees, and built a multi-stage diligence process and deal assessment framework. • Spearheaded investment practices across life sciences, healthcare, artificial intelligence, and deep technology infrastructure sectors. • Developed a proprietary investment sourcing pipeline of 4,000+ opportunities screened and conducted extensive buy-side market and technical research to develop the firm’s portfolio sector and stage allocation model.• Composed 50+ in-depth investment memorandums for investment committees, conducted quarterly portfolio monitoring and reporting, and led deal negotiations, including structuring, financing, and closing transactions.• Operationally supported 40 portfolio companies with multiple board-level positions and assisted CEOs with $250M+ in capital raises, M&A diligence, technology development, executive hiring, and launching 5+ products to market. -
PrincipalHarmonix Fund Sep 2020 - Nov 2020La Quinta, California, Us• Implemented institutional due diligence process and led investment analysis, technical diligence, and deal sourcing in building top-decile performing Fund I. -
Senior AssociateHarmonix Fund Apr 2020 - Sep 2020La Quinta, California, Us -
AnalystHarmonix Fund Nov 2019 - Apr 2020La Quinta, California, Us -
InvestorQu Biologics Inc. Nov 2020 - Aug 2024Burnaby, British Columbia, Ca -
InvestorAncilia Biosciences Nov 2020 - Aug 2024 -
InvestorRad Ai Aug 2020 - Aug 2024San Francisco, California, Us -
InvestorAuransa Aug 2020 - Aug 2024Palo Alto, California, Us -
InvestorViscient Bio Inc Aug 2020 - Aug 2024San Diego, California, Us -
InvestorInsilico Medicine Jul 2020 - Aug 2024Boston, Massachusetts, Us -
InvestorJuvena Therapeutics Jun 2020 - Aug 2024Palo Alto, Ca, Us -
InvestorPragma Bio May 2020 - Aug 2024South San Francisco, California, Us -
InvestorAbalone Bio May 2020 - Aug 2024Emeryville, Ca, Us -
InvestorSentiar Apr 2020 - Aug 2024St. Louis, Missouri, Us -
InvestorAtlas Space Operations, Inc. Apr 2020 - Aug 2024Traverse City, Michigan, Us -
InvestorTarana Wireless, Inc. Mar 2020 - Aug 2024Milpitas, California, Us -
InvestorHalo Industries, Inc. Mar 2020 - Aug 2024Santa Clara, Ca, Us -
InvestorGen1E Lifesciences Inc. Feb 2020 - Aug 2024Palo Alto, California, Us -
InvestorPathologywatch Dec 2020 - Jan 2024Salt Lake City, Ut, Us$150M M&A by Sonic Healthcare -
InvestorTrials.Ai Dec 2020 - Jan 2023Princeton, New Jersey, UsAcquired by ZS Associates -
InvestorVolumetric Jun 2020 - May 2022Houston, Texas, Us$400M M&A by 3D Systems -
Research AssistantMassachusetts Institute Of Technology Nov 2017 - Mar 2019Cambridge, Ma, Us• Evaluated over $1 billion in VC-funded and bootstrapped entrepreneurial business ventures using 3 statement and excel-based financial models to forecast financing activity. The resulting analysis was used in MIT case studies.• Developed written briefs and reports examining bootstrapped startups, critically analyzing the deployment of innovation taxonomies in early-stage entrepreneurial ventures.• Research featured in the book: “Reimagining Innovation in Humanitarian Medicine” (Springer-Nature Press, 2018). -
Research AssistantHarvard'S Belfer Center May 2017 - Jun 2018Cambridge, Ma, Us• Collaborated on the Science, Technology, and Globalization Project with Calestous Juma, Ph.D. focusing on the applications of cutting-edge technology to improve human health and economic development in 10+ African countries.• Researched affordable healthcare solutions and biomedical device applications in low-resource settings to improve the health outcomes for 50+ million people in sub-Saharan Africa. • Resulting research was published in the internationally-released scientific book “Bio-Based Material as Applicable, Accessible, and Affordable Healthcare Solutions” (2018). -
Research AssistantTaubman Center For State & Local Government Feb 2016 - Jul 2017Cambridge, Massachusetts, Us• Conducted portfolio analysis on the United States Agency for International Development (USAID) Development Innovation Ventures portfolio ($149M portfolio, 190+ investments, 5x ROI) with Nobel Laureate Economist, Michael Kremer, Ph.D. • Portfolio and investment analysis work published in the governmental report “Lower Bounds on the benefit-cost ratio and social rate of Return of USAID’s Development Innovation Ventures Portfolio”.
Krish W. Ramadurai Skills
Krish W. Ramadurai Education Details
-
University Of OxfordEngineering Science -
University Of OxfordNanotechnology For Medicine (Nanomedicine) -
Washington University In St. Louis - Olin Business SchoolMba -
Harvard UniversityBiology -
University Of Illinois Urbana-ChampaignIntegrative Biology And Economics With Chemistry Minor
Frequently Asked Questions about Krish W. Ramadurai
What company does Krish W. Ramadurai work for?
Krish W. Ramadurai works for Aix Ventures
What is Krish W. Ramadurai's role at the current company?
Krish W. Ramadurai's current role is Partner at AIX Ventures | Author.
What is Krish W. Ramadurai's email address?
Krish W. Ramadurai's email address is kr****@****ard.edu
What schools did Krish W. Ramadurai attend?
Krish W. Ramadurai attended University Of Oxford, University Of Oxford, Washington University In St. Louis - Olin Business School, Harvard University, University Of Illinois Urbana-Champaign.
What are some of Krish W. Ramadurai's interests?
Krish W. Ramadurai has interest in Poverty Alleviation, Science And Technology, Economic Empowerment, Health.
What skills is Krish W. Ramadurai known for?
Krish W. Ramadurai has skills like Teamwork, Research, Spanish, Data Analysis, Microsoft Excel, Microsoft Office, Leadership, Project Management, Spss, Python, Powerpoint, Microsoft Word.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial